ArticleBioengineered2021

MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer's disease.

Wenjun Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.